News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
99,602 Results
Type
Article (4394)
Company Profile (13)
Press Release (95195)
Section
Business (40342)
Career Advice (174)
Deals (6675)
Drug Delivery (11)
Drug Development (10344)
Employer Resources (16)
FDA (1655)
Job Trends (2155)
News (56339)
Policy (2525)
Tag
Academia (327)
Africa (77)
Alliances (6010)
Alzheimer's disease (182)
Approvals (1655)
Arizona (15)
Artificial intelligence (14)
Asia (6664)
Australia (753)
Bankruptcy (40)
Best Places to Work (1760)
Biotechnology (13)
C2C Services and Suppliers (9735)
California (345)
Canada (302)
Cancer (65)
Career advice (140)
Cell therapy (23)
China (18)
Clinical research (8246)
Collaboration (19)
Colorado (10)
Connecticut (19)
COVID-19 (194)
Cystic fibrosis (18)
Data (70)
Delaware (13)
Diabetes (10)
Diagnostics (908)
Drug pricing (8)
Earnings (19467)
Employer resources (14)
Europe (14279)
Events (16673)
Executive appointments (44)
FDA (1687)
Florida (29)
Funding (65)
Gene therapy (11)
GLP-1 (70)
Government (267)
Healthcare (2835)
Hotbed/Location (69301)
Illinois (43)
Indiana (34)
Infectious disease (196)
Inflammatory bowel disease (21)
Interviews (31)
IPO (3706)
Job creations (411)
Job search strategy (123)
Kansas (12)
Layoffs (40)
Legal (386)
Lung cancer (31)
Maine (28)
Manufacturing (9)
Maryland (47)
Massachusetts (268)
Medical device (2288)
Medtech (2290)
Mergers & acquisitions (2961)
Metabolic disorders (26)
Michigan (12)
Minnesota (22)
Neuroscience (199)
New Jersey (74)
New York (108)
NextGen Class of 2024 (1333)
Non-profit (611)
North Carolina (88)
Northern California (163)
Obesity (16)
Ohio (28)
Opinion (51)
Pennsylvania (89)
People (10948)
Phase I (2359)
Phase II (3810)
Phase III (2875)
Pipeline (34)
Policy (10)
Postmarket research (237)
Preclinical (932)
Rare diseases (26)
Real estate (709)
Regulatory (1941)
Research institute (269)
Resumes & cover letters (30)
Series A (22)
South America (174)
Southern California (145)
Startups (2209)
Texas (29)
United States (1383)
Vaccines (24)
Venture capitalists (9)
Virginia (8)
Washington State (31)
Weight loss (8)
Date
Today (25)
Last 7 days (137)
Last 30 days (452)
Last 365 days (7149)
2024 (5033)
2023 (7097)
2022 (9874)
2021 (9143)
2020 (8718)
2019 (7882)
2018 (6063)
2017 (5104)
2016 (4363)
2015 (5280)
2014 (3751)
2013 (2830)
2012 (3137)
2011 (3419)
2010 (3403)
99,602 Results for "5am ventures".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis
Karius®, Inc., a world leader in genomic diagnostics for infectious disease, announced it has secured $100 million in Series C funding.
May 2, 2024
·
5 min read
Business
BioMarin to Present at the 22nd Annual Morgan Stanley Global Healthcare Conference on Thursday, September 5 at 7:45 AM PT / 10:45 AM ET in New York, NY
August 29, 2024
·
1 min read
Startups
BridgeBio Launches GondolaBio With $300M, Transfers Programs to Joint Venture
With the help of third-party investors, the new venture will focus on three genetic and rare diseases: tuberous sclerosis complex, erythropoietic protoporphyria and alpha-A1 antitrypsin deficiency.
August 22, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Syntax Bio Launches with Strategic Backing from Astellas Venture Management LLC and Illumina Ventures
September 17, 2024
·
1 min read
Pharm Country
JOGO Health Closes $5.5M in Round Led by Hourglass Ventures, Extends Investment Opportunity for Public to Invest Alongside Mayo Clinic Ventures
JOGO Health, a medtech company treating chronic pain and neuromuscular disorders, announced it has closed over $5.5 million in an investment round led by Hourglass Ventures.
June 18, 2024
·
2 min read
Press Releases
Somite Therapeutics Announces Round Extension with Astellas Venture Management and Montage Ventures Joining as Board Observers
September 3, 2024
·
3 min read
Business
Integrated Biosciences Joins Illumina Ventures Labs to Design Novel Therapeutics Targeting the Transcriptome
Integrated Biosciences today announced they have joined Illumina Ventures Labs to integrate the company’s drug discovery engine with Illumina sequencing.
May 28, 2024
·
3 min read
Lone Star Bio
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
VenoStent, Inc. announced that it closed an additional $4 million from Norwest Venture Partners to round out its Series A financing at $20 million with Good Growth Capital and IAG Capital Partners co-leading the deal.
June 27, 2024
·
4 min read
BioSyent Named to 2024 TSX Venture 50
BioSyent Inc. is pleased to announce that it has been named to the 2024 TSX Venture 50 list as one of the top performers on the TSX Venture Exchange.
February 21, 2024
·
2 min read
J.P. Morgan Raises Over $500M for First Biotech Venture Capital Fund
J.P. Morgan’s life sciences venture capital arm on Thursday announced it closed its first biotech fund, targeting companies in cardiometabolic disease, immunology, oncology and genetic medicine.
June 14, 2024
·
2 min read
·
Tyler Patchen
1 of 9,961
Next
